PSI Newsletter
The PSI Newsletter is an email communication that contains patient safety and regulatory information, learning and development opportunities, and resources of interest to pharmacists, pharmacy owners and all those working in pharmacy-related roles, and wider stakeholders. The newsletter is sent automatically to PSI registrants. We welcome all others to sign up here to be added to the subscriber list.
PSI Newsletter: Issue 1, 2024
- Expert Taskforce to support the expansion of the role of pharmacists in Ireland
- Prescription validity extended up to 12 months
- Changes to legislation impacting emergency supply of medicines including controlled drugs
- Antimicrobial resistance and stewardship – resources for pharmacists and the public
- HPRA Medicines Safety Updates: Valproate and Topiramate
- Effective counselling on prescribed medicines to enhance patient understanding
- Spring COVID-19 Booster Campaign – Updates to Training Modules
- Safe sales of paracetamol in pharmacy settings: Upcoming survey
- Call for Expressions of Interest from community pharmacists and their teams to participate in an in-pharmacy photoshoot for the PSI
- Learning from an Inquiry
- Fitness to Practise and Mediation Outcomes
- Nurse prescribers authorised to prescribe Lisdexamfetamine
- Coming soon: New PSI website
- PSI roadshows events: Resources